vimarsana.com
Home
Live Updates
Co Primary Symptom Endpoint Met - Breaking News
Pages:
Latest Breaking News On - Co primary symptom endpoint met - Page 1 : vimarsana.com
Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)
On an Intent-to-Treat Analysis, Co-Primary Symptom Endpoint Met, Statistical Significance (P<0.025) Multiple Secondary Symptom Endpoints Met, Statistical.
United states
Securities exchange
Company to host conference call
Palatin technologies inc
Prnewswire palatin technologies inc
Intent to treat analysis
Co primary symptom endpoint met
Statistical significance
Secondary symptom endpoints met
Co primary sign endpoint
Secondary sign endpoints not
Superiority over vehicle
Multiple sign
Discussions planned
Regulatory approval
Host conference call
vimarsana © 2020. All Rights Reserved.